Yet, a recent study demonstrates that post infusion of CAR T cells, tumor specimens in glioblastoma patients have markedly increased expression of many immunosuppressive molecules, particularly IDO1 and FoxP3, and in some cases, IL-10, PD-L1, and/or TGF-β [29]. The gene discussed is IL10; the disease is glioblastoma.